VFA
ANIK icon

Voya Financial Advisors’s Anika Therapeutics ANIK Stock Holding History

Voya Financial Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,012
Closed -$269K – 660
2020
Q4 		$269K Buy
+6,012
New +$228K 0.01% 544
2020
Q3 		– Sell
-6,671
Closed -$232K – 586
2020
Q2 		$232K Sell
6,671
-922
-12% -$30.4K 0.01% 526
2020
Q1 		$217K Sell
7,593
-414
-5% -$16.7K 0.01% 514
2019
Q4 		$419K Sell
8,007
-731
-8% -$42.5K 0.02% 433
2019
Q3 		$471K Sell
8,738
-314
-3% -$16.1K 0.03% 397
2019
Q2 		$357K Sell
9,052
-222
-2% -$8.1K 0.02% 451
2019
Q1 		$277K Buy
9,274
+96
+1% +$3.29K 0.02% 498
2018
Q4 		$293K Buy
9,178
+843
+10% +$30.4K 0.02% 436
2018
Q3 		$352K Buy
8,335
+1,499
+22% +$59.2K 0.02% 446
2018
Q2 		$214K Buy
6,836
+1,802
+36% +$74.2K 0.01% 520
2018
Q1 		$249K Buy
5,034
+1,057
+27% +$59.7K 0.02% 478
2017
Q4 		$212K Buy
3,977
+218
+6% +$12.1K 0.01% 521
2017
Q3 		$219K Buy
+3,759
New +$197K 0.01% 475

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Voya Financial Advisors's ANIK Position: Q1 2021 in Review

Voya Financial Advisors sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 6,012 shares — an estimated $269K sold.

Voya Financial Advisors first reported a position in ANIK in Q3 2017 and held it in 13 quarters. The position peaked at $471K in Q3 2019. 145 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • Voya Financial Advisors reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 6,012 Anika Therapeutics shares in Q1 2021, an estimated $269K.
  • Voya Financial Advisors first reported a position in Anika Therapeutics in Q3 2017 and held it in 13 quarters.
  • Voya Financial Advisors's Anika Therapeutics position peaked at $471K in Q3 2019.
  • 145 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on Voya Financial Advisors's 13F filing for Q1 2021, filed 17 May 2021.